Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2023 17:00 ET | Source: FACT.MR

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Projected to Reach US$ 45.51 Billion by 2034: Fact.MR Study

Rockville , Dec. 10, 2023 (GLOBE NEWSWIRE) -- Expanding at 6.2% CAGR from 2024 to 2034, the global attention deficit hyperactivity disorder (ADHD) therapeutics market is estimated to reach a...
March 04, 2020 09:00 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Announces Entry into Option Agreement to License GABA(A) Receptor Allosteric Neuromodulator Intellectual Property from the UWM Research Foundation, Inc.

Glen Rock, N.J., March 04, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the research and development of ampakines for a variety...